The FDA has approved J&J’s Covid-19 vaccine for emergency use, giving the U.S. a third tool to fight the pandemic.
Unlike Pfizer’s and Moderna’s vaccines, J&J’s one-ose regimen eliminates the need for patients to return for a second dose and it can be stored at refrigerator temperatures for months.
The federal government plans to distribute nearly 4 million doses of J&J’s vaccine to states, pharmacies and community health centers across the nation next week.
FDA approves Johnson & Johnson’s single-shot Covid vaccine for emergency use
The FDA has approved J&J’s Covid-19 vaccine for emergency use, giving the U.S. a third tool to fight the pandemic.
Unlike Pfizer’s and Moderna’s vaccines, J&J’s one-ose regimen eliminates the need for patients to return for a second dose and it can be stored at refrigerator temperatures for months.
The federal government plans to distribute nearly 4 million doses of J&J’s vaccine to states, pharmacies and community health centers across the nation next week.